Images and videos
Images
Menopause
Absolute rates of stroke for different types of hormone therapy (HT) compared with no HT (or placebo), different durations of HT use, and time since stopping HT for menopausal women.
National Institute for Health and Care Excellence. Menopause: diagnosis and management. Dec 2019
See this image in context in the following section/s:
Menopause
Absolute rates of coronary heart disease for different types of hormone therapy (HT) compared with no HT (or placebo), different durations of HT use, and time since stopping HT for menopausal women.
National Institute for Health and Care Excellence. Menopause: diagnosis and management. Dec 2019
See this image in context in the following section/s:
Menopause
Summary of HRT risks and benefits* during current use and current use plus post-treatment from age of menopause up to age 69 years, per 1000 women with 5 years or 10 years use of HRT. Key: *Menopausal symptom relief is not included in this table, but is a key benefit of HRT and will play a major part in the decision to prescribe HRT. †Best estimates based on relative risks of HRT use from age 50. For breast cancer this includes cases diagnosed during current HRT use and diagnosed after HRT use until age 69 years; for other risks, this assumes no residual effects after stopping HRT use. § Latest evidence suggests that transdermal HRT products have a lower risk of VTE than oral preparations
Medicines and Healthcare products Regulatory Agency. Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping. Aug 2019 [internet publication]; used with permission
See this image in context in the following section/s:
Use of this content is subject to our disclaimer